Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
作者信息
Zeevi A, Eiras G, Burckart G, Jain A, Kragack A, Venkataramanan R, Todo S, Fung J, Starzl T E, Duquesnoy R J
机构信息
Division of Clinical Immunopathology, School of Pharmacy, Prebyterian-University Hospital, University of Pittsburgh, PA 15213-2582.
出版信息
Transplant Proc. 1990 Feb;22(1):60-3.
Abstract
摘要
相似文献
1
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.对接受FK 506免疫抑制治疗的肝移植患者血浆样本进行生物测定。
Transplant Proc. 1990 Feb;22(1):60-3.
2
3
Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.肝移植受者中用于测定FK 506的MEIA法与ELISA法之间的相关性研究。
J Clin Pharm Ther. 1997 Apr;22(2):135-40. doi: 10.1111/j.1365-2710.1997.tb00007.x.
4
Immunocompetence assay for net effect of combined immunosuppression.联合免疫抑制净效应的免疫能力测定。
Transplant Proc. 2001 May;33(3):2350-1. doi: 10.1016/s0041-1345(01)02018-8.
5
In vitro assessment of FK 506 immunosuppressive activity in transplant patients.移植患者中FK 506免疫抑制活性的体外评估。
Transplant Proc. 1991 Dec;23(6):2897-9.
6
Distribution of FK 506 in plasma lipoproteins in transplant patients.移植患者血浆脂蛋白中FK 506的分布
Transplant Proc. 1991 Feb;23(1 Pt 2):954-5.
7
8
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens.
Transplant Proc. 1996 Oct;28(5):2471-3.
9
Assay of FK 506 in plasma.血浆中FK 506的测定
Transplant Proc. 1990 Feb;22(1):50-1.
10
引用本文的文献
1
Mechanisms of clinically relevant drug interactions associated with tacrolimus.与他克莫司相关的临床显著药物相互作用机制。
Clin Pharmacokinet. 2002;41(11):813-51. doi: 10.2165/00003088-200241110-00003.
2
Clinically significant drug interactions with new immunosuppressive agents.新型免疫抑制剂的具有临床意义的药物相互作用。
Drug Saf. 1997 Apr;16(4):267-78. doi: 10.2165/00002018-199716040-00004.
3
The use of therapeutic drug monitoring to optimise immunosuppressive therapy.使用治疗药物监测来优化免疫抑制治疗。
Clin Pharmacokinet. 1996 Feb;30(2):107-40. doi: 10.2165/00003088-199630020-00003.
4
Clinical pharmacokinetics of tacrolimus.他克莫司的临床药代动力学
Clin Pharmacokinet. 1995 Dec;29(6):404-30. doi: 10.2165/00003088-199529060-00003.
5
Tacrolimus analysis: a comparison of different methods and matrices.他克莫司分析：不同方法与基质的比较
Ther Drug Monit. 1995 Apr;17(2):159-67. doi: 10.1097/00007691-199504000-00010.
6
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
7
The effect of FK 506 on peripheral blood T-lymphocyte subsets in orthotopic liver transplant patients.FK506对原位肝移植患者外周血T淋巴细胞亚群的影响。
Transplant Proc. 1991 Dec;23(6):2937-8.
8
In vitro assessment of FK 506 immunosuppressive activity in transplant patients.移植患者中FK 506免疫抑制活性的体外评估。
Transplant Proc. 1991 Dec;23(6):2897-9.
9
Distribution of FK 506 in plasma lipoproteins in transplant patients.移植患者血浆脂蛋白中FK 506的分布
Transplant Proc. 1991 Feb;23(1 Pt 2):954-5.
本文引用的文献
1
Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.
Transplantation. 1985 Nov;40(5):457-76. doi: 10.1097/00007890-198511000-00001.
2
Cyclosporine trough concentration monitoring in liver transplant patients.肝移植患者环孢素谷浓度监测
Transplant Proc. 1986 Dec;18(6 Suppl 5):188-93.
3
New approaches in the use of cyclosporine: with particular reference to the liver.环孢素使用的新方法：特别涉及肝脏方面。
Transplant Proc. 1988 Jun;20(3 Suppl 3):356-60.
4
Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.肾移植受者中环孢素与高剂量类固醇的相互作用：通过高效液相色谱法进行评估。
Transplant Proc. 1987 Feb;19(1 Pt 2):1728-9.
5
Immunopharmacodynamic profiles in children with renal allografts receiving cyclosporine therapy.接受环孢素治疗的肾移植儿童的免疫药效学特征。
Am J Kidney Dis. 1988 Aug;12(2):104-9. doi: 10.1016/s0272-6386(88)80003-9.
6
Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release.
J Immunogenet. 1985 Feb;12(1):17-31. doi: 10.1111/j.1744-313x.1985.tb00826.x.
7
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.新型免疫抑制剂FK 506对大鼠异位心脏同种异体移植的影响。
Transplant Proc. 1987 Feb;19(1 Pt 2):1284-6.
8
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
9
Renal transplantation in baboons under FK 506.在使用FK506的情况下狒狒的肾移植
Surgery. 1989 Aug;106(2):444-50; discussion 450-1.
Zotero 插件